论文部分内容阅读
目的:探讨经尿道等离子电切术(PKRP)治疗良性前列腺增生症(BPH)的临床疗效,评价其安全性及可行性。方法:抽选2013年8月至2016年8月我院泌尿外科门诊收治的115例BPH患者,随机分为两组,观察组(n=65)行PKRP,对照组(n=50)行传统经尿道前列腺电切术(TURP),对比两组近远期疗效指标。结果:观察组近期疗效指标(手术时间、出血量、住院时间)及远期疗效指标(IPSS、Qmax)均明显优于对照组,p<0.05,有统计学意义。结论:经尿道等离子电切术治疗良性前列腺增生症近远期疗效都比较理想,有利于改善患者生活质量,值得进一步推广。
Objective: To investigate the clinical efficacy of transurethral plasmakinetic excision (PKRP) in the treatment of benign prostatic hyperplasia (BPH) and evaluate its safety and feasibility. Methods: One hundred and fifteen patients with BPH admitted to Department of Urology in our hospital from August 2013 to August 2016 were randomly divided into two groups. The patients in observation group (n = 65) underwent PKRP and the control group (n = 50) Transurethral resection of the prostate (TURP), compared two groups of short-term efficacy indicators. Results: The short term efficacy index (operation time, blood loss, hospital stay) and long-term efficacy index (IPSS, Qmax) of the observation group were significantly better than the control group, p <0.05, with statistical significance. Conclusion: Transurethral resection of the plasma in the treatment of benign prostatic hyperplasia in the short-term and long-term efficacy are ideal, is conducive to improving the quality of life of patients, it is worth further promotion.